Ubigene Showcases CRISPR-iScreen™ Platform for Precision CRISPR Screening
NEW YORK, January 2026 – Ubigene, a global biotechnology innovator specializing in precision gene editing solutions, today highlights its proprietary CRISPR-iScreen™ platform, a high-efficiency CRISPR screening technology designed to support both in vivo and in vitro functional genomics research. The platform addresses growing industry demand for more reliable, scalable, and biologically relevant screening strategies in…